Scott Koenig - 19 May 2023 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
GLYC
Transactions as of
19 May 2023
Net transactions value
$0
Form type
4
Filing time
22 May 2023, 16:24:14 UTC
Previous filing
17 Feb 2023
Next filing
02 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLYC Stock Option (right to buy) Award $0 +35,000 $0.000000 35,000 19 May 2023 Common Stock 35,000 $1.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date.